Basaglar and Overdose - a phase IV clinical study of FDA data

Summary:

Overdose is reported as a side effect among people who take Basaglar (insulin glargine), especially for people who are female, 60+ old, also take Humalog, and have Diabetes.

The phase IV clinical study analyzes which people have Overdose when taking Basaglar. It is created by eHealthMe based on reports of 19,751 people who have side effects when taking Basaglar from the FDA, and is updated regularly.

What is Basaglar?

Basaglar has active ingredients of insulin glargine. eHealthMe is studying from 19,807 Basaglar users. Check the latest studies of Basaglar.

What is Overdose?

Overdose is found to be associated with 2,220 drugs and 2,471 conditions by eHealthMe. Check the latest studies of Overdose.

On Jul, 11, 2026

19,751 people reported to have side effects when taking Basaglar.
Among them, 27 people (0.14%) have Overdose.

Among these 27 people:

What is the gender of people who have Overdose when taking Basaglar? *

female: 61.54 %
male: 38.46 %

What is the age of people who have Overdose when taking Basaglar? *

What are other drugs people take besides Basaglar? *

What are other side effects people have besides Overdose? *

Blood Glucose Decreased: 3 people, 11.11%
Blood Glucose Increased: 3 people, 11.11%
Memory Loss: 3 people, 11.11%
Diarrhea: 3 people, 11.11%
Localised Infection (infection at the single location): 2 people, 7.41%
Headache (pain in head): 2 people, 7.41%
Tremor (trembling or shaking movements in one or more parts of your body): 2 people, 7.41%
Hypoglycemia (low blood sugar): 2 people, 7.41%
High Blood Pressure: 2 people, 7.41%
Hyperhidrosis (abnormally increased sweating): 2 people, 7.41%

What are the existing conditions these people have? *

Diabetes: 10 people, 37.04%
Type 2 Diabetes: 4 people, 14.81%
High Blood Pressure: 3 people, 11.11%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 7.41%
Depression: 2 people, 7.41%
Indigestion: 2 people, 7.41%
High Blood Cholesterol: 2 people, 7.41%
Type 1 Diabetes: 2 people, 7.41%
Constipation: 1 person, 3.70%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 3.70%

* Approximation only. Some reports may have incomplete information.

Do you take Basaglar and have Overdose?

- Check whether Overdose is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Basaglar:

Basaglar (19,807 reports)

Overdose treatments and more:

Overdose (229,245 reports)

Browse all side effects of Basaglar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Overdose:

Overdose (2,220 drugs)

Browse all the conditions that are associated with Overdose:

Overdose (2,471 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on insulin glargine (the active ingredients of Basaglar) and Basaglar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.